Expert Consensus for the Surgical Management of Gastroesophageal Reflux Disease Combined with Obesity (2025)

doi:10.3877/cma.j.issn.2095-8765.2025.04.001

Abstract

Working Group of Surgical Experts for the Diagnosis and Treatment of Gastroesophageal Reflux Disease, Surgeons Branch of Chinese Medical Doctor Association, Surgery Branch of Chinese Medical Association, Specialty Committee for Bariatric and Metabolic Surgery, Surgical Expert Committee, National Committee of Health Capacity Building and Continuing Education, National Health Commission of the People’s Republic of China. Expert Consensus for the Surgical Management of Gastroesophageal Reflux Disease Combined with Obesity (2025)[J]. Chinese Journal of Gastroesophageal Reflux Disease(Electronic Edition), 2025, 12(04): 123-138.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhwsgflbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-8765.2025.04.001

https://zhwsgflbdzzz.cma-cmc.com.cn/EN/Y2025/V12/I04/123

Figures/Tables 1

References 87

1	Chang P, Friedenberg F. Obesity and gerd [J]. Gastroenterol Clin North Am, 2014, 43(1): 161-173.
2	Eusebi LH, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis [J]. Gut, 2018, 67(3): 430-440.
3	Zhang D, Liu S, Li Z, et al. Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: Update from the gbd 2019 study [J]. Ann Med, 2022, 54(1): 1372-1384.
4	Tang Z, Chen Z, Huang Y, et al. Trends in the burden of gastroesophageal reflux disease in China and Global from 1990 to 2021 and predictive analysis for 2040 [J]. PLoS One, 2026, 21(2): e0341619.
5	El-Serag HB, Graham DY, Satia JA, et al. Obesity is an independent risk factor for gerd symptoms and erosive esophagitis [J]. Am J Gastroenterol, 2005, 100(6): 1243-1250.
6	Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications [J]. Ann Intern Med, 2005, 143(3): 199-211.
7	Murray L, Johnston B, Lane A, et al. Relationship between body mass and gastro-oesophageal reflux symptoms: the bristol helicobacter project [J]. Int J Epidemiol, 2003, 32(4): 645-650.
8	Nirwan JS, Hasan SS, Babar ZU, et al. Global prevalence and risk factors of gastro-oesophageal reflux disease (gord): systematic review with meta-analysis [J]. Sci Rep, 2020, 10(1): 5814.
9	Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal reflux in women [J]. N Engl J Med, 2006, 354(22): 2340-2348.
10	King K, Sudan R, Bardaro S, et al. Assessment and management of gastroesophageal reflux disease following bariatric surgery [J]. Surg Obes Relat Dis, 2021, 17(11): 1919-1925.
11	Lee HL, Eun CS, Lee OY, et al. Association between gerd-related erosive esophagitis and obesity [J]. J Clin Gastroenterol, 2008, 42(6): 672-675.
12	Singh S, Sharma AN, Murad MH, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis [J]. Clin Gastroenterol Hepatol, 2013, 11(11): 1399-1412.e1397.
13	Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: A pooled analysis from the international beacon consortium [J]. Int J Epidemiol, 2012, 41(6): 1706-1718.
14	Suter M, Dorta G, Giusti V, et al. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients [J]. Obes Surg, 2004, 14(7): 959-966.
15	Pandolfino JE, El-Serag HB, Zhang Q, et al. Obesity: A challenge to esophagogastric junction integrity [J]. Gastroenterology, 2006, 130(3): 639-649.
16	Qi Z, Shi X C, Yan WM, et al. Association of esophageal hiatus size with reflux esophagitis and type I hiatal hernia in patients with obesity [J]. World J Radiol, 2025, 17(5): 106333.
17	国家卫生健康委员会肥胖症诊疗指南编写委员会, 张忠涛, 纪立农. 肥胖症诊疗指南(2024年版) [J]. 中国循环杂志, 2025, 40(1): 6-30.
18	Sadafi S, Azizi A, Pasdar Y, et al. Risk factors for gastroesophageal reflux disease: A population-based study [J]. BMC Gastroenterol, 2024, 24(1): 64.
19	Taraszewska A. Risk factors for gastroesophageal reflux disease symptoms related to lifestyle and diet [J]. Rocz Panstw Zakl Hig, 2021, 72(1): 21-28.
20	Gorodner V, Viscido G, Signorini F, et al. Gastroesophageal reflux disease and morbid obesity: Evaluation and treatment [J]. Updates Surg, 2018, 70(3): 331-337.
21	Dent J, Vakil N, Jones R, et al. Accuracy of the diagnosis of gord by questionnaire, physicians and a trial of proton pump inhibitor treatment: the DIAMOND study [J]. Gut, 2010, 59(6): 714-721.
22	Jones R, Junghard O, Dent J, et al. Development of the gerdq, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care [J]. Aliment Pharmacol Ther, 2009, 30(10): 1030-1038.
23	Velanovich V. 25 years of the gerd-hrql symptom severity instrument: An assessment of published applications [J]. Surg Endosc, 2023, 37(1): 255-265.
24	Bello B, Zoccali M, Gullo R, et al. Gastroesophageal reflux disease and antireflux surgery-what is the proper preoperative work-up? [J]. J Gastrointest Surg, 2013, 17(1): 14-20; discussion p. 20.
25	中国医师协会外科医师分会胃食管反流病专业委员, 汪忠镐, 克力木·阿不都热依木, 等. 成人胃食管反流病外科诊疗共识（2022版）[J/OL]. 中华胃食管反流病电子杂志, 2022, 09(4): 174-180.
26	Gyawali CP, Yadlapati R, Fass R, et al. Updates to the modern diagnosis of gerd: Lyon consensus 2.0 [J]. Gut, 2024, 73(2): 361-371.
27	Fennerty MB, Johnson DA. Heartburn severity does not predict disease severity in patients with erosive esophagitis [J]. MedGenMed, 2006, 8(2): 6.
28	中国医疗保健国际交流促进会胃食管反流病学分会. 中国胃食管反流病多学科诊疗共识2022（二） [J/OL]. 中华胃食管反流病电子杂志, 2022, 9(3): 112-146.
29	Chen J, Brady P. Gastroesophageal reflux disease: Pathophysiology, diagnosis, and treatment [J]. Gastroenterol Nurs, 2019, 42(1): 20-28.
30	Bonaldi M, Rubicondo C, Andreasi V, et al. Role of preoperative high-resolution manometry in the identification of patients at high risk of postoperative gerd symptoms 1 year after sleeve gastrectomy [J]. Obes Surg, 2023, 33(9): 2749-2757.
31	中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 精准肥胖代谢外科手术中国专家共识（2022版） [J]. 中华消化外科杂志, 2022, 21(10): 1302-1312.
32	Avgerinos KI, Spyrou N, Mantzoros CS, et al. Obesity and cancer risk: Emerging biological mechanisms and perspectives [J]. Metabolism, 2019, 92: 121-135.
33	Park J, Morley TS, Kim M, et al. Obesity and cancer--mechanisms underlying tumour progression and recurrence [J]. Nat Rev Endocrinol, 2014, 10(8): 455-465.
34	Iyengar NM, Gucalp A, Dannenberg AJ, et al. Obesity and cancer mechanisms: Tumor microenvironment and inflammation [J]. J Clin Oncol, 2016, 34(35): 4270-4276.
35	Avila C, Holloway AC, Hahn MK, et al. An overview of links between obesity and mental health [J]. Curr Obes Rep, 2015, 4(3): 303-310.
36	M D EH, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care [J]. World Psychiatry, 2011, 10(1): 52-77.
37	Remington G. Schizophrenia, antipsychotics, and the metabolic syndrome: is there a silver lining? [J]. Am J Psychiatry, 2006, 163(7): 1132-1134.
38	Law S, Dong S, Zhou F, et al. Bariatric surgery and mental health outcomes: an umbrella review [J]. Front Endocrinol (Lausanne), 2023, 14: 1283621.
39	Park SK, Lee T, Yang HJ, et al. Weight loss and waist reduction is associated with improvement in gastroesophageal disease reflux symptoms: a longitudinal study of 15295 subjects undergoing health checkups [J]. Neurogastroenterol Motil, 2017, 29(5).
40	Monteiro Delgado L, Fabretina de Souza V, Fontel Pompeu B, et al. Long-term outcomes in sleeve gastrectomy versus roux-en-y gastric bypass: A systematic review and meta-analysis of randomized trials [J]. Obes Surg, 2025, 35(8): 3246-3257.
41	Rebecchi F, Allaix ME, Giaccone C, et al. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: a physiopathologic evaluation [J]. Ann Surg, 2014, 260(5): 909-914; discussion 914-905.
42	DuPree CE, Blair K, Steele SR, et al. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis [J]. JAMA Surg, 2014, 149(4): 328-334.
43	Qumseya BJ, Qumsiyeh Y, Ponniah SA, et al. Barrett’s esophagus after sleeve gastrectomy: A systematic review and meta-analysis [J]. Gastrointest Endosc, 2021, 93(2): 343-352.e342.
44	Brown WA, Johari Halim Shah Y, Balalis G, et al. Ifso position statement on the role of esophago-gastro-duodenal endoscopy prior to and after bariatric and metabolic surgery procedures [J]. Obes Surg, 2020, 30(8): 3135-3153.
45	Hussein AH, Khaled I, Faisal M. The role of the surgical resection distance from the pylorus after laparoscopic sleeve gastrectomy: A prospective cohort study from an academic medical center in egypt [J]. Patient Saf Surg, 2020, 14(1): 42.
46	Meimand FE, Pazouki A, Setaredan SA, et al. The effect of antral resection start point on post sleeve gastrectomy gastroesophageal reflux symptoms and weight loss outcomes [J]. Surg Endosc, 2023, 37(7): 5158-5163.
47	McGlone ER, Gupta AK, Reddy M, et al. Antral resection versus antral preservation during laparoscopic sleeve gastrectomy for severe obesity: Systematic review and meta-analysis [J]. Surg Obes Relat Dis, 2018, 14(6): 857-864.
48	Diab AF, Kim A, Remmel S, et al. Antral preservation in sleeve gastrectomy appears to protect against prolonged vomiting and gastroesophageal reflux disease. A meta-analysis of randomized controlled trials [J]. Obes Surg, 2023, 33(12): 4103-4114.
49	Al-Tai S, Axer S, Szabo E, et al. The impact of the bougie size and the extent of antral resection on weight-loss and postoperative complications following sleeve gastrectomy: Results from the scandinavian obesity surgery registry [J]. Surg Obes Relat Dis, 2024, 20(2): 139-145.
50	Jumaev N, Teshaev O, Lim I, et al. Calibration bougie size selection in sleeve gastrectomy: a systematic review and meta-analysis [J]. Obes Surg, 2025, 35(8): 3221-3227.
51	中国医师协会外科医师分会肥胖和代谢病专家工作组, 中国医师协会外科医师分会胃食管反流疾病诊疗外科专家工作组, 日本肥胖治疗学会, 等. 袖状胃切除术患者胃食管反流病诊治专家共识（2024版） [J/OL]. 中华胃食管反流病电子杂志, 2024, 11(2): 57-74.
52	Lyyjynen HS, Andersen JR, Liem RSL, et al. Surgical aspects of sleeve gastrectomy are related to weight loss and gastro-esophageal reflux symptoms [J]. Obes Surg, 2024, 34(3): 902-910.
53	Wilson LJ, Ma W, Hirschowitz BI. Association of obesity with hiatal hernia and esophagitis [J]. Am J Gastroenterol, 1999, 94(10): 2840-2844.
54	Dong H, Du X, Zhao J, et al. Risk factors associated with hiatal hernia: A retrospective study and two-sample mendelian randomization [J]. Surg Endosc, 2025, 39(7): 4128-4136.
55	中国医师协会外科医师分会胃食管反流病专业学组, 新疆维吾尔自治区胃食管反流病与减重代谢外科临床医学研究中心, 新疆维吾尔自治区普外微创研究所, 等. 成人机器人辅助食管裂孔疝修补抗反流手术中国专家共识(2024版) [J]. 中国普通外科杂志, 2025, 34(4): 595-599.
56	Hider AM, Bonham AJ, Carlin AM, et al. Impact of concurrent hiatal hernia repair during laparoscopic sleeve gastrectomy on patient-reported gastroesophageal reflux symptoms: a state-wide analysis [J]. Surg Obes Relat Dis, 2023, 19(6): 619-625.
57	Soricelli E, Iossa A, Casella G, et al. Sleeve gastrectomy and crural repair in obese patients with gastroesophageal reflux disease and/or hiatal hernia [J]. Surg Obes Relat Dis, 2013, 9(3): 356-361.
58	Chen W, Feng J, Wang C, et al. Effect of concomitant laparoscopic sleeve gastrectomy and hiatal hernia repair on gastroesophageal reflux disease in patients with obesity: a systematic review and meta-analysis [J]. Obes Surg, 2021, 31(9): 3905-3918.
59	Hashemi M, Peters JH, DeMeester TR, et al. Laparoscopic repair of large type Ⅲ hiatal hernia: Objective followup reveals high recurrence rate [J]. J Am Coll Surg, 2000, 190(5): 553-560; discussion 560-551.
60	Luostarinen M, Rantalainen M, Helve O, et al. Late results of paraoesophageal hiatus hernia repair with fundoplication [J]. Br J Surg, 1998, 85(2): 272-275.
61	尹杰, 杨慧琪, 逯景辉. 食管裂孔疝修补材料的选择及固定的专家微共识 [J/OL]. 中华疝和腹壁外科杂志(电子版), 2022, 16(1): 1-7.
62	Saber AA, Shoar S, Khoursheed M. Intra-thoracic sleeve migration (itsm): An underreported phenomenon after laparoscopic sleeve gastrectomy [J]. Obes Surg, 2017, 27(8): 1917-1923.
63	Elmaleh HM, Elnabeel Mortada A, Khaled RA. Evaluation of anterior phrenoesophageal ligament preservation during hiatus hernia repair in laparoscopic sleeve gastrectomy as an anti-reflux measure [J]. J Laparoendosc Adv Surg Tech A, 2021, 31(5): 507-514.
64	Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the sm-boss randomized clinical trial [J]. JAMA, 2018, 319(3): 255-265.
65	Salminen P, Grönroos S, Helmiö M, et al. Effect of laparoscopic sleeve gastrectomy vs roux-en-y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the sleevepass randomized clinical trial [J]. JAMA Surg, 2022, 157(8): 656-666.
66	Campos GM, Mazzini GS, Altieri MS, et al. Asmbs position statement on the rationale for performance of upper gastrointestinal endoscopy before and after metabolic and bariatric surgery [J]. Surg Obes Relat Dis, 2021, 17(5): 837-847.
67	Han Y, Jia Y, Wang H, et al. Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: a systematic review and meta-analysis based on 18 studies [J]. Int J Surg, 2020, 76: 101-110.
68	克力木·阿不都热依木, 艾克拜尔·艾力, 伊比提哈尔, 等. 腹腔镜胃底折叠术联合胃袖状切除术治疗肥胖合并胃食管反流病 [J]. 中华普通外科杂志, 2015, 30(6): 458-461.
69	玉素江·图荪托合提, 艾克拜尔·艾力, 麦麦提艾力·麦麦提明, 等. 肥胖合并胃食管反流病的外科治疗研究进展 [J/OL]. 中华胃食管反流病电子杂志, 2022, 9(3): 165-169.
70	Olmi S, Caruso F, Uccelli M, et al. Laparoscopic sleeve gastrectomy combined with rossetti fundoplication (r-sleeve) for treatment of morbid obesity and gastroesophageal reflux [J]. Surg Obes Relat Dis, 2017, 13(12): 1945-4950.
71	皮尔地瓦斯·麦麦提玉素甫, 艾克拜尔·艾力, 买买提·依斯热依力, 等. 腹腔镜胃底折叠术联合胃袖状切除术治疗肥胖合并胃食管反流病临床研究 [J]. 中国实用外科杂志, 2020, 40(4): 437-440, 443.
72	Aili A, Maimaitiming M, Maimaitiyusufu P, et al. Gastroesophageal reflux related changes after sleeve gastrectomy and sleeve gastrectomy with fundoplication: a retrospective single center study [J]. Front Endocrinol (Lausanne), 2022, 13: 1041889.
73	艾克拜尔·艾力, 玉素江·图荪托合提, 克力木·阿不都热依木. 胃底折叠术对预防胃袖状切除术后胃食管反流病的价值 [J]. 中国实用外科杂志, 2024, 44(8): 884-888.
74	玉素江·图荪托合提, 麦麦提艾力·麦麦提明, 克力木·阿不都热依木, 等. 机器人辅助与腹腔镜袖状胃切除联合Dor胃底折叠术治疗肥胖合并胃食管反流病近期疗效的对比分析 [J]. 中华普通外科杂志, 2025, 40(6): 445-450.
75	Tusuntuoheti Y, Maimaitiming M, Maimaitiyusufu P, et al. The mid-term efficacy of sleeve-nissen versus sleeve-toupet fundoplication for the management of gastroesophageal reflux disease in patients with obesity [J]. Obes Surg, 2025, 35(9): 3858-3868.
76	Felsenreich DM, Arnoldner MA, Wintersteller L, et al. Intrathoracic pouch migration in one-anastomosis gastric bypass with and without hiatoplasty: A 3-dimensional-computed tomography volumetry study [J]. Surg Obes Relat Dis, 2023, 19(5): 492-499.
77	Carbajo MA, Luque-de-León E, Jiménez JM, et al. Laparoscopic one-anastomosis gastric bypass: Technique, results, and long-term follow-up in 1200 patients [J]. Obes Surg, 2017, 27(5): 1153-1167.
78	Esparham A, Ahmadyar S, Zandbaf T, et al. Does one-anastomosis gastric bypass expose patients to gastroesophageal reflux: A systematic review and meta-analysis [J]. Obes Surg, 2023, 33(12): 4080-4102.
79	Cao K, Zhai Z, Shi X, et al. The short-term effect of laparoscopic sleeve gastrectomy with his angle reconstruction (lsg-his) on gastroesophageal reflux disease [J]. BMC Gastroenterol, 2025, 25(1): 611.
80	朱孝成, 王键, 洪健, 等. 胃袖状切除联合双通路术对预防胃袖状切除术后胃食管反流病的价值 [J]. 中国实用外科杂志, 2024, 44(8): 880-884.
81	Azagury D, Morton J. Surgical anti-reflux options beyond fundoplication [J]. Curr Gastroenterol Rep, 2017, 19(7): 35.
82	Bonavina L, DeMeester TR, Ganz RA. Linx(™) reflux management system: Magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease [J]. Expert Rev Gastroenterol Hepatol, 2012, 6(6): 667-674.
83	Cammarata F, Novia M, Aiolfi A, et al. Magnetic sphincter augmentation for gastroesophageal reflux after sleeve gastrectomy: a systematic review [J]. Obes Surg, 2024, 34(11): 4232-4243.
84	朱孝成, 侯栋升. 新型减重代谢手术方式:袖状胃切除加双通路 [J]. 外科理论与实践, 2020, 25(5): 391-396.
85	中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 肥胖与代谢病外科疗效报告的标准规范 [J/OL]. 中华肥胖与代谢病电子杂志, 2020, 6(2): 73-77.
86	Fox M, Gyawali CP. Dietary factors involved in gerd management [J]. Best Pract Res Clin Gastroenterol, 2023, 62-63: 101826.
87	Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after roux-en-y gastric bypass, incidence, risk factors, and patient presentation: a systematic review [J]. Obes Surg, 2014, 24(2): 299-309.

术式	主要证据类型/随访	证据质量（GRADE）	推荐强度定位
SG联合His角重建术	单中心研究为主，随访多为短期	低	弱推荐；待验证
SG联合双通路术	回顾性/小样本研究为主	低	弱推荐；待验证
SG联合MSA置入术	多为病例系列，随访多为短期	极低	待验证（装置相关风险需评估）
OAGB	研究结果不一致，部分为回顾性/队列与系统评价	低	弱推荐；需明确胆汁反流风险
BPD-DS、SASI、SADI-S	证据有限，国内应用较少	极低	不推荐常规开展；限经验中心/研究条件下

术式	主要证据类型/随访	证据质量（GRADE）	推荐强度定位
SG联合His角重建术	单中心研究为主，随访多为短期	低	弱推荐；待验证
SG联合双通路术	回顾性/小样本研究为主	低	弱推荐；待验证
SG联合MSA置入术	多为病例系列，随访多为短期	极低	待验证（装置相关风险需评估）
OAGB	研究结果不一致，部分为回顾性/队列与系统评价	低	弱推荐；需明确胆汁反流风险
BPD-DS、SASI、SADI-S	证据有限，国内应用较少	极低	不推荐常规开展；限经验中心/研究条件下

Please choose a citation manager

Content to export